Thomas Nørrelykke Nissen

Author

Also Known As

Davies, LSC, Jesper Kjærgaard, T NISSEN, T Nissen, T. N. Nissen, THOMAS NISSEN, Thomas N. Nissen, Thomas Nissen, Thomas Nørrelykke Nissen

Publications

625

Citations

H-Index

Concepts

All Affiliations

Hvidovre Hospital Statens Serum Institut Copenhagen University Hospital Rigshospitalet Odense University Hospital

About

Thomas Nørrelykke Nissen is an author at Hvidovre Hospital specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	94
2	Immunology	3	3	94
3	Gastroenterology	1	1	14
4	Pathology	1	1	14
5	Autoimmune Disease	1	1	14

Thomas Nørrelykke Nissen

Publications

577

Citations

H-Index

Page 1

	Year	Citations
BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter Trial Lone Graff Stensballe, Henrik Ravn, Nina Marie Birk, Journal of the Pediatric Infectious Diseases Society	2018	69
BCG vaccination at birth and early childhood hospitalisation: a randomised clinical multicentre trial Lone Graff Stensballe, Signe Sørup, Peter Aaby, Archives of Disease in Childhood	2016	61
Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial Jesper Kjærgaard, Nina Marie Birk, Thomas Nørrelykke Nissen, Pediatric Research VaccinationVaccine SafetyBcg VaccinationMaternal ImmunizationClinical Multicenter Trial	2016	56
Adaptive Immunity against <i>Streptococcus pyogenes</i> in Adults Involves Increased IFN-γ and IgG3 Responses Compared with Children Rasmus Mortensen, Thomas Nørrelykke Nissen, Thomas Blauenfeldt, The Journal of Immunology	2015	53
QuantiFERON®-TB Gold In-Tube Performance for Diagnosing Active Tuberculosis in Children and Adults in a High Burden Setting Michala Vaaben Rose, Godfather Kimaro, Thomas Nørrelykke Nissen, PLoS ONE	2012	48
Neonatal <scp>BCG</scp> vaccination and atopic dermatitis before 13 months of age: A randomized clinical trial Lisbeth Marianne Thøstesen, Jesper Kjærgaard, Gitte Thybo Pihl, Allergy	2017	46
Adverse reactions to the Bacillus Calmette–Guérin (BCG) vaccine in new-born infants—an evaluation of the Danish strain 1331 SSI in a randomized clinical trial Thomas Nørrelykke Nissen, Nina Marie Birk, Jesper Kjærgaard, Vaccine	2016	33
Bacillus Calmette-Guérin immunisation at birth and morbidity among Danish children: A prospective, randomised, clinical trial Lisbeth Marianne Thøstesen, Thomas Nørrelykke Nissen, Jesper Kjærgaard, Contemporary Clinical Trials	2015	30
Bacille Calmette-Guérin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial Thomas Nørrelykke Nissen, Nina Marie Birk, Gaby Smits, Vaccine	2017	30
Neonatal <scp>BCG</scp> has no effect on allergic sensitization and suspected food allergy until 13 months Lisbeth Marianne Thøstesen, Henrik Fomsgaard Kjær, Gitte Thybo Pihl, Pediatric Allergy and Immunology	2017	26

Page 1